These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34043923)

  • 1. Outcomes of a Pharmacist-Led Hepatitis C Virus Treatment Program in an Urban Safety-Net Health System, Chicago, 2017-2019.
    Hunt BR; Cetrone H; Sam S; Glick NR
    Public Health Rep; 2022; 137(4):702-710. PubMed ID: 34043923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist-led drug therapy management for hepatitis C at a federally qualified health care center.
    Downes JM; Donovan A; McAdam-Marx C
    J Am Pharm Assoc (2003); 2022; 62(5):1596-1605. PubMed ID: 35595639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
    Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Regional Analysis of Hepatitis C Virus Collaborative Care With Pharmacists in Indian Health Service Facilities.
    Geiger R; Steinert J; McElwee G; Carver J; Montanez R; Niewoehner J; Clark C; Reilley B
    J Prim Care Community Health; 2018; 9():2150132718807520. PubMed ID: 30348039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.
    Tsertsvadze T; Gamkrelidze A; Chkhartishvili N; Abutidze A; Sharvadze L; Kerashvili V; Butsashvili M; Metreveli D; Gvinjilia L; Shadaker S; Nasrullah M; Adamia E; Zeuzem S; Afdhal N; Arora S; Thornton K; Skaggs B; Kuchuloria T; Lagvilava M; Sergeenko D; Averhoff F
    Clin Infect Dis; 2020 Aug; 71(5):1263-1268. PubMed ID: 31563938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
    Gauthier TP; Moreira E; Chan C; Cabrera A; Toro M; Carrasquillo MZ; Corentin M; Sherman EM
    J Am Pharm Assoc (2003); 2016; 56(6):670-676. PubMed ID: 27667501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital.
    Tran AN; Sachdev R; Fricker ZP; Leber M; Zahorian T; Shah B; Nunes DP; Long MT
    Dig Dis Sci; 2018 Dec; 63(12):3241-3249. PubMed ID: 30078116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine Screening and Linkage to Care for Hepatitis C Virus in an Urban Safety-Net Health System, 2017-2019.
    Hunt BR; Ahmed C; Ramirez-Mercado K; Patron C; Glick NR
    Public Health Rep; 2021; 136(2):219-227. PubMed ID: 33176114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of pharmacist care delivery models for hepatitis C clinics.
    Naidjate SS; Zullo AR; Dapaah-Afriyie R; Hersey ML; Marshall BDL; Winkler RM; Berard-Collins C
    Am J Health Syst Pharm; 2019 May; 76(10):646-653. PubMed ID: 30873537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal.
    Burgui C; San Miguel R; Goñi-Esarte S; Juanbeltz R; Úriz-Otano JI; Reparaz J; Sarobe M; Zozaya JM; Castilla J
    Postgrad Med; 2023 May; 135(4):352-360. PubMed ID: 36305320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus micro-elimination within a clinic for people with HIV: challenges in the home stretch.
    Hanna J; Sufian J; Suh JS; Jimenez HR
    HIV Med; 2022 Aug; 23(7):801-806. PubMed ID: 35150183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the hepatitis C cure cascade in an Urban health system using the electronic health record.
    Miller LS; Millman AJ; Lom J; Osinubi A; Ahmed F; Dupont S; Rein D; Vellozzi C; Harris AM
    J Viral Hepat; 2020 Jan; 27(1):13-19. PubMed ID: 31505088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
    Isho NY; Kachlic MD; Marcelo JC; Martin MT
    J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.
    Nordstrom EM; Keniston A; Baouchi F; Martinez-Camacho A
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):10-16. PubMed ID: 27755117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program.
    Winetsky D; Burack D; Antoniou P; Garcia B; Gordon P; Scherer M
    J Infect Dis; 2020 Sep; 222(Suppl 5):S392-S400. PubMed ID: 32877544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population.
    Stewart RA; MacDonald BR; Chu TC; Moore JD; Fasanmi EO; Ojha RP
    Dig Dis Sci; 2018 Dec; 63(12):3233-3240. PubMed ID: 30014226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to the Treatment of Hepatitis C among Predominantly African American Patients Seeking Care in an Urban Teaching Hospital in Washington, D.C.
    Liu L; Daftary MN; Alzahrani MS; Ohanele C; Maneno MK
    J Natl Med Assoc; 2021 Apr; 113(2):147-157. PubMed ID: 32868101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.